200,000+ products from a single source!
sales@angenechem.com
Home > Quinoline > 111073-34-8
111073-34-8 | 2(1H)-Quinolinone,7-[3-[4-(2,3-dimethylphenyl)-1-piperazinyl]propoxy]-
CAS No: 111073-34-8 Catalog No: AG007TTS MDL No:
Product Description
Catalog Number:
AG007TTS
Chemical Name:
2(1H)-Quinolinone,7-[3-[4-(2,3-dimethylphenyl)-1-piperazinyl]propoxy]-
CAS Number:
111073-34-8
Molecular Formula:
C24H29N3O2
Molecular Weight:
391.5060
IUPAC Name:
7-[3-[4-(2,3-dimethylphenyl)piperazin-1-yl]propoxy]-1H-quinolin-2-one
InChI:
InChI=1S/C24H29N3O2/c1-18-5-3-6-23(19(18)2)27-14-12-26(13-15-27)11-4-16-29-21-9-7-20-8-10-24(28)25-22(20)17-21/h3,5-10,17H,4,11-16H2,1-2H3,(H,25,28)
InChI Key:
RRLWEQBPSAFVAS-UHFFFAOYSA-N
SMILES:
Cc1cccc(c1C)N1CCN(CC1)CCCOc1ccc2c(c1)[nH]c(=O)cc2
Properties
Complexity:
573
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
391.226g/mol
Formal Charge:
0
Heavy Atom Count:
29
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
391.515g/mol
Monoisotopic Mass:
391.226g/mol
Rotatable Bond Count:
6
Topological Polar Surface Area:
44.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4
Literature
| Title | Journal |
|---|---|
| Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review. | Annals of general psychiatry 20090101 |
| Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis. | Annals of general psychiatry 20090101 |
| Differences in agonist/antagonist properties at human dopamine D(2) receptors between aripiprazole, bifeprunox and SDZ 208-912. | European journal of pharmacology 20071128 |
| In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling. | Journal of psychopharmacology (Oxford, England) 20070801 |
| Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic. | European journal of pharmacology 20050516 |
| Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 19990601 |
Related Products
© 2019 Angene International Limited. All rights Reserved.